Caggiano Anthony has filed 14 insider transactions across 1 company since February 2024.
Most recent transaction: a tax payment of 4680 shares of COGNITION THERAPEUTICS INC ($CGTX) on February 15, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 15, 2026 | COGNITION THERAPEUTICS INC | $CGTX | Caggiano Anthony | Chief Medical Officer | F | Common Stock | 4680 | $1.12 | 864,906.0000 | 77,951,513 | 0.54% | 0.01% |
| Feb. 4, 2026 | COGNITION THERAPEUTICS INC | $CGTX | Caggiano Anthony | Chief Medical Officer | F | Common Stock | 26919 | $1.03 | 869,586.0000 | 77,951,513 | 3.00% | 0.03% |
| Feb. 3, 2026 | COGNITION THERAPEUTICS INC | $CGTX | Caggiano Anthony | Chief Medical Officer | F | Common Stock | 11488 | $1.12 | 896,505.0000 | 77,951,513 | 1.27% | 0.01% |
| Feb. 3, 2026 | COGNITION THERAPEUTICS INC | $CGTX | Caggiano Anthony | Chief Medical Officer | A | Common Stock | 400000 | $0.00 | 907,993.0000 | 77,951,513 | 78.74% | 0.51% |
| Dec. 18, 2025 | COGNITION THERAPEUTICS INC | $CGTX | Caggiano Anthony | Chief Medical Officer | F | Common Stock | 20280 | $1.50 | 507,993.0000 | 77,951,513 | 3.84% | 0.03% |
| Dec. 18, 2025 | COGNITION THERAPEUTICS INC | $CGTX | Caggiano Anthony | Chief Medical Officer | A | Common Stock | 65000 | $0.00 | 528,273.0000 | 77,951,513 | 14.03% | 0.08% |
| July 29, 2025 | COGNITION THERAPEUTICS INC | $CGTX | Caggiano Anthony | Chief Medical Officer | A | Common Stock | 65000 | $0.00 | 483,554.0000 | 63,690,945 | 15.53% | 0.10% |
| July 29, 2025 | COGNITION THERAPEUTICS INC | $CGTX | Caggiano Anthony | Chief Medical Officer | F | Common Stock | 20281 | $0.67 | 463,273.0000 | 63,690,945 | 4.19% | 0.03% |
| Feb. 15, 2025 | COGNITION THERAPEUTICS INC | $CGTX | Caggiano Anthony | Chief Medical Officer | F | Common Stock | 5296 | $0.59 | 418,554.0000 | 39,730,148 | 1.25% | 0.01% |
| Feb. 4, 2025 | COGNITION THERAPEUTICS INC | $CGTX | Caggiano Anthony | Chief Medical Officer | A | Common Stock | 295000 | $0.00 | 423,850.0000 | 39,730,148 | 228.95% | 0.74% |
| Feb. 3, 2025 | COGNITION THERAPEUTICS INC | $CGTX | Caggiano Anthony | Chief Medical Officer | F | Common Stock | 12779 | $0.67 | 128,850.0000 | 39,730,148 | 9.02% | 0.03% |
| Feb. 15, 2024 | COGNITION THERAPEUTICS INC | $CGTX | Caggiano Anthony | Chief Medical Officer | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 30,029,087 | 9999.99% | 0.20% |
| Feb. 15, 2024 | COGNITION THERAPEUTICS INC | $CGTX | Caggiano Anthony | Chief Medical Officer | A | Common Stock | 60000 | $0.00 | 141,629.0000 | 30,029,087 | 73.50% | 0.20% |
| Feb. 3, 2024 | COGNITION THERAPEUTICS INC | $CGTX | Caggiano Anthony | Chief Medical Officer | F | Common Stock | 12777 | $2.29 | 81,629.0000 | 30,029,087 | 13.53% | 0.04% |